Latest filing published 09 Apr 2015 for Amarantus Bioscience Holdings, Inc., €9,354.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -99.2%Entry US$7.68 · Close at T+365 US$0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Edward Farrell: trading record in brief
Robert Edward Farrell discloses dealings in 2 companies, chiefly Titan Pharmaceuticals Inc and Amarantus Bioscience Holdings, Inc. Between 20 March 2007 and 9 April 2015, the trades on record add up to 12 filings.
Purchases make up the whole of the open-market record (11 purchases, €98k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. 2015 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €5,514.
The newest entry dates from 9 April 2015: an open-market purchase of €9,354, in Amarantus Bioscience Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Edward Farrell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ US$0.0499Common StockSEC:0001144204-15-022015:0Canonical exit: 8 Jul 2015 (T+90)
- 133,333 shares@ US$0.075Common StockSEC:0001144204-14-069999:0Canonical exit: 17 Feb 2015 (T+90)
- 200,000 shares0Common StockSEC:0001181431-08-058024:0
- 5,050 shares@ US$1.61Common StockSEC:0001181431-08-002050:0Canonical exit: 2 Apr 2008 (T+90)
- 3,950 shares@ US$1.61Common StockSEC:0001181431-08-002050:1Canonical exit: 3 Apr 2008 (T+90)
- 15,500 shares@ US$2.14Common StockSEC:0001181431-07-028189:0Canonical exit: 26 Jul 2007 (T+90)
- 400 shares@ US$2.29Common StockSEC:0001181431-07-020852:0Canonical exit: 18 Jun 2007 (T+90)
- 4,000 shares@ US$2.34Common StockSEC:0001181431-07-020852:1Canonical exit: 18 Jun 2007 (T+90)
- 2,100 shares@ US$2.31Common StockSEC:0001181431-07-020852:2Canonical exit: 18 Jun 2007 (T+90)
- 100 shares@ US$2.30Common StockSEC:0001181431-07-020852:3Canonical exit: 18 Jun 2007 (T+90)
- 1,000 shares@ US$2.32Common StockSEC:0001181431-07-020852:4Canonical exit: 18 Jun 2007 (T+90)
- 18,400 shares@ US$2.40Common StockSEC:0001181431-07-020852:5Canonical exit: 18 Jun 2007 (T+90)
12 of 12 declarations